Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Medstar Antalya Hospital uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 2009, this institution is based in Ankara, Turkey, and has 124 beds, with JCI recognition, to assist both local and foreign patients.
The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.
Vinmec Smart City Hospital employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2020, the JCI accredited hospital is located in Ha noi, Vietnam and has 500 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
OncoCare Cancer Centre uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 2020, this institution is based in Amroha, India, and it has adequate bed capacity, with NABH recognition, to assist both local and foreign patients.
The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.
Vinmec Da Nang employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2017, the JCI accredited hospital is located in Da Nang, Vietnam and has 222 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
Vinmec Nha Trang has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The JCI accredited establishment of the year 2017 is situated in Nha Trang, Vietnam, and contains 150 beds.
CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.
The Vinmec Can Tho Hospital is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 2016, the JCIcertified hospital is situated in Can Tho, Vietnam, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 155.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
The Fortis Hiranandani Hospital is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 2007, the NABHcertified hospital is situated in Mumbai, India, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 149.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
Fortis Hospital, Shalimar Bagh employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2010, the NABH accredited hospital is located in Delhi, India and has 262 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
Delhi, India
The Max Smart Super Speciality Hospital is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 2012, the JCI, NABHcertified hospital is situated in Delhi, India, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 250.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
Max Super Specialty Hospital, Shalimar Bagh uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 2011, this institution is based in Delhi, India, and has 402 beds, with NABH, NABL recognition, to assist both local and foreign patients.
The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.
Amrita Hospital uses advanced cellular manufacturing techniques and immunotherapy protocols to provide CAR T-cell therapy services. Founded in 2022, this institution is based in Faridabad, India, and has 2600 beds, with NABH recognition, to assist both local and foreign patients.
The CAR-T process is beneficial for some patients with blood cancers that have failed prior treatment and returned, depending on the disease type and the approved indication. In CAR-T therapy, T cells are collected, engineered to recognise cancer cells, multiplied, and then infused back after proper preparation of the cells. The cancer treatment team performs a careful assessment of the disease and health history before individualisation of treatment.
Ajman, United Arab Emirates
Thumbay University Hospital, Ajman employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2002, the JCI accredited hospital is located in Ajman, United Arab Emirates and has 350 beds and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
Meliva Kardiolita Hospital, Kaunas has advanced infrastructure for cellular therapy and provides CAR T-cell therapy to patients with specific types of blood cancers. The JCI accredited establishment of the year 1998 is situated in Kaunas, Lithuania, and contains 8 beds.
CAR-T therapy is a form of immunotherapy in which the patient's immune system is engineered to target and destroy cancerous cells. The execution of the therapy involves cell collection, laboratory enhancement processes, chemotherapy, and infusion. Patients are monitored carefully before, during, and after treatment, as they may experience immune-related complications.
The Bukit Tinggi Medical Centre is equipped with innovative CAR-T Cell Therapy, employing cutting-edge cellular immunotherapy methodologies in compliance with widely accepted global protocols for patient treatment. Founded in 2016, the MSQHcertified hospital is situated in Kuala Lumpur, Malaysia, offering specialised cancer treatment services to both local and international clientele, with a total bed count of 171.
CAR-T treatment is a personalised treatment process where a patient’s T cells are extracted, subsequently modified so that they can identify tumors in a patient’s body. The treatment process is indicated for some blood cancers, particularly some types of lymphomas, leukemias, and multiple myeloma. Medical professionals conduct various tests to determine a patient’s prior treatments, health status, and diagnoses before initiating the CAR-T treatment program.
Rajagiri Hospital employs modern cell immunotherapy technology and evidence-based cancer treatment in CAR-T Cell Therapy. Founded in 2014, the JCI accredited hospital is located in Kochi, India and it has adequate bed capacity and facilities for local and international patients.
CAR-T Cell Therapy involves extracting T cells and processing them to recognise a specific cancer antigen before increasing their number in the body. Depending on the cancer treatment used, patients may undergo lymphodepleting chemotherapy before receiving CAR-T cells. The multidisciplinary team assesses all aspects of the disease, past treatment regimens, organ function, and suitability for treatment.
| Speciality | Oncology |
| Procedure | CAR-T |
| Success Rate | Varies as per stage, grade, type and location of cancer |
| Recovery Time | Few days to several weeks |
| Treatment Time | Several weeks or even months |
| Chances of Recurrence | Varies as per stage, grade, type and location of cancer |
Leukaemia is a blood disease that arises from the bone marrow and produces white blood cells. Many patients recover from chemotherapy, targeted therapy, or stem cell transplantation,
